Linda Ashcroft

Corinne Faivre-Finn1
Sally Falk1
1Corinne Faivre-Finn
1Sally Falk
Learn More
  • Kate Haslett, Kevin Franks, Gerard G Hanna, Susan Harden, Matthew Hatton, Stephen Harrow +9 others
  • 2016
INTRODUCTION The majority of stage III patients with non-small cell lung cancer (NSCLC) are unsuitable for concurrent chemoradiotherapy, the non-surgical gold standard of care. As the alternative treatment options of sequential chemoradiotherapy and radiotherapy alone are associated with high local failure rates, various intensification strategies have been(More)
  • 1